Find On This Page

Related Information

  Funding for Special   Communities

Encapsulation & Immunoprotective Strategies of Islet Cells

Washington, DC
December 6-7, 2001
 
Sponsored by
Juvenile Diabetes Research Foundation International
National Aeronautics and Space Administration
National Istitute of Diabetes and Digestive and Kidney Diseases
National Center for Research Resources

Summary

For nearly 20 years, research on encapsulating transplanted islet cells as a means of preventing rejection by the body’s immune system has seen little progress. However, with isolated reports of success in a few experiments, the promise remains.

On December 6-7, 2001, more than 60 leading scientists from eight countries and other key individuals participated in a workshop to review the current state of encapsulation technology and to develop a strategy for the best use of a $2 million appropriation that the National Aeronautics and Space Administration will be directing toward research in this area.

Held near Washington, DC, the workshop included presentations from scientists on the latest technology, advances, and results in the field of encapsulation. Sessions were divided into four key areas: encapsulation and immunobarriers, industry perspectives, immunoprotective and anti-inflammatory therapies, and gene therapy for islet immunoprotection.

* Documents in PDF format require the free Adobe Acrobat Reader Exit Disclaimer Iconapplication for viewing.

Page last updated: January 01, 0001

General inquiries may be addressed to:
Office of Communications & Public Liaison
NIDDK, NIH
Bldg 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
USA
301.496.3583

The National Institutes of Health   Department of Health and Human Services   USA.gov is the U.S. government's official web portal to all federal, state, and local government web resources and services.  This website is certified by Health On the Net Foundation. Click to verify.